14th Annual Updates in the Treatment and Management of Hematologic Malignancies Highlights from San Diego
The 14th Annual Updates in the Treatment and Management of Hematologic Malignancies Highlights from San Diego provides an invaluable educational experience highlighting the latest advances in malignant and non-malignant hematology. Please join us and engage with experts to learn and gain practical insights on current therapies, and innovative treatments. Available on-demand, this activity ensures that health care professionals caring for these patients have unlimited access to the latest scientific updates, innovative ideas, and pressing issues in their field. Participants can gain valuable insights ultimately improving the care and outcomes of patients with hematologic m
Target Audience
The intended audience is medical oncologists, hematologists and advanced practice providers.
Learning Objectives
At the conclusion of this activity, participants should be able to:
- Participants will be able to identify appropriate therapeutic strategies based on the most current evidence, ensuring optimal patient selection for novel treatments in lymphoma, leukemia, and multiple myeloma.
- Demonstrate an improved ability to anticipate, recognize, and manage toxicities related to therapies, leading to enhanced patient safety and better clinical outcomes.
- Analyze the latest clinical trial data and FDA- approved therapies for the treatment of hematologic malignancies, including CAR-T therapy, bispecific antibodies, and small-molecule inhibitors.
Required Hardware/software
We recommend the following hardware/software to successfully view and complete the contents of this course:
| Recommended Desktop Parameters | For ease of use, we strongly recommend using a desktop computer to complete this course. The following desktop web browsers are compatible with our system: Desktop: Chrome, Internet Explorer, MS Edge, Safari |
| Recommended Mobile Parameters | While not recommended, if you are familiar with completing courses online you may complete this course using a mobile device. For those wishing to complete this activity on Mobile, the following systems are recommended: Apple iPhones and iPad devices on iOS 10 or later |
If you encounter any issues while accessing our courses, please contact [email protected]

Facebook
X
LinkedIn
Forward